Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471419 · ClinicalTrials.gov registry record · Phase 3
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 750
- Enrollment target
NCT00471419 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 750 participants.
The verdict
NCT00471419, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 750 participants
- Enrollment target
Study Summary
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
Interventions
- DRUG Rimexolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00471419
The ClinicalTrials.gov registry entry for NCT00471419 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rimexolone is the first listed.
NCT00471419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00471419 about?
NCT00471419 is a clinical study titled "Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye". The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
What is the current status of trial NCT00471419?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 750 participants. The study started on 2006-07. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00471419?
The interventions under investigation include: Rimexolone (DRUG).
Who is sponsoring clinical trial NCT00471419?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.